Medtronic plc (NYSE:MDT) Q1 2024 Earnings Call Transcript August 22, 2023 8:00 AM ET
Company Participants
Ryan Weispfenning - VP and Head of IR
Geoff Martha - Chairman and CEO
Karen Parkhill - CFO
Brad Welnick - VP, IR
Que Dallara - EVP and President, Diabetes
Mike Marinaro - EVP and President, Surgical and Endoscopy
Sean Salmon - EVP and President, Cardiovascular
Conference Call Participants
Vijay Kumar - Evercore ISI
Robbie Marcus - JPMorgan
Larry Biegelsen - Wells Fargo Securities
Danielle Antalffy - UBS
Travis Steed - Bank of America
Matt Miksic - Barclays
Chris Pasquale - Nephron
Jayson Bedford - Raymond James
Joanne Weunsch - Citi
Patrick Wood - Morgan Stanley
Ryan Weispfenning
Good morning, I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. I appreciate that you're joining us today for our Fiscal 2024 First Quarter Video Earnings Webcast. We're broadcasting to you today from our operational headquarters here in Minnesota where summer is in full force.
Before we go inside to hear our prepared remarks, I'll share a few details about today's webcast. Joining me are Geoff Martha, Medtronic Chairman and Chief Executive Officer; and Karen Parkhill, Medtronic Chief Financial Officer. Geoff and Karen will provide comments on the results of our first quarter, which ended on July 28, 2023, and our outlook for the remainder of the fiscal year. After our prepared remarks, the executive VPs from each of our four segments will join us, and we'll take questions from the sell-side analysts that cover the company. Today's program should last about an hour.
Earlier this morning, we issued a press release containing our financial statements and divisional and geographic revenue summaries. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press release or on
- Read more current MDT analysis and news
- View all earnings call transcripts